Skip to content
Trial Eligibility
Menu

Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy

NCT07664956

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Minimally Invasive Surgical Procedures
  • Abnormal Uterine Bleeding, Unspecified
  • Adenomyosis of Uterus
  • Fibroid Uterus
  • Chronic Pelvic Pain
  • Endometriosis
  • Menorrhagia
  • Endometritis
  • Adnexal Diseases

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 years and older
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Christiana Care Health Services
Last updated on ClinicalTrials.gov
November 20, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Delaware · 1

  • ChristianaCare Health System · Newark, DE

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.